Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Cancer confirmed by histology or cytology~* At least one measurable lesion~* Advanced disease refractory to standard therapy or for which no standard therapy exists~* Life expectancy of at least 3 months~Exclusion Criteria:~* Known secondary neoplasia or central nervous system (CNS) metastases; acute or chronic leukemia, lymphoma or multiple myeloma~* Body weight below 45 kg~* Female patients who are pregnant or breast feeding or adults of reproductive potential not employing effective method of birth control~* Confirmed diagnosis of HIV~* Insulin dependent diabetes mellitus / abnormal glucose tolerance test (GTT) / latent diabetes mellitus type I or II~* Chemotherapy or radiotherapy less than 4 weeks prior to entry~* Surgery less than 2 weeks prior to entry (or not recovered from effects of surgery)~* Participation in a clinical trial less than 30 days prior to entry in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- AMT2003 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).